Key facts
- In May 2025, 686 measles cases were reported by 17 countries in the EU/EEA. Thirteen countries reported zero cases.
- Overall, six measles-related deaths have been reported in the EU/EEA in 2025, two from France, one from the Netherlands and three from Romania.
- Overall, case numbers decreased compared with the previous month; this is consistent with the seasonality of measles.
Overview
In May 2025, 30 countries reported measles data in the EU/EEA, with 686 measles cases reported by 17 countries. There were 13 countries that reported zero cases.
Overall, case numbers decreased compared with the previous month; which is consistent with the seasonality of the disease. The highest case counts were reported by Romania (162), France (134), Belgium (126), Italy (72) and the Netherlands (54).
Between 1 June 2024 and 31 May 2025, 30 EU/EEA Member States reported a total of 17 940 cases of measles, 12 694 (70.8%) of which were laboratory confirmed. Of the total reported cases with known age, 7 732 (43.1%) were in children under five years; 5 243 (29.2%) cases were aged 15 years or above. The highest notification rates were observed among infants under one year of age (602.4 cases per million) and children aged 1-4 years (333.2 cases per million).
Of 16 360 cases (100.0% of all cases) with a known age and vaccination status, 13 968 (85.4%) were unvaccinated, 1 446 (8.8%) were vaccinated with one dose of a measles-containing vaccine, 883 (5.4%) were vaccinated with two or more doses, and 39 (0.2%) were vaccinated with an unknown number of doses.
During the 12-month period, 11 deaths (case fatality rate (CFR): 0.1) attributable to measles were reported to ECDC by Romania (eight), France (two) and the Netherlands (one). Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.
Complementary epidemic intelligence surveillance has been conducted, with data collection between 11 and 13 June 2025. Ongoing outbreaks or considerable increases were reported in Belgium (Flanders region), Germany (Bavaria region), and Romania. Sporadic cases have been reported in Austria, Czechia, Denmark, Estonia, Italy, Lithuania, the Netherlands, Poland, Slovakia, and Spain.
Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy and EpiPulse. Data presented in the two monthly reports may differ.
Epidemiological summary for EU/EEA countries with relevant epidemic intelligence updates:
Austria has reported 133 measles cases in 2025 and as of 2 July 2025, an increase of 17 cases since 11 June 2025. In the last four weeks, cases have been reported from Vienna, Lower Austria, Upper Austria and Steiermark. Relevant information was available for 123 cases, 31 of which were hospitalised (25.2%), including one patient who was being treated in intensive care unit.
Czechia had reported 30 cases as of 1 July 2025, an increase of 14 cases since 1 June 2025.
France: an increase in cases and the number of outbreaks has been observed in 2025 and this trend has been continuing since 2023. According to the national public health authorities, the number of cases in the first five months of 2025 (658 cases, including two deaths among immunocompromised patients) is already exceeding the number of cases reported in 2024 by 35% (483 cases; 0.58 cases per 100 000 population). Among the subjects targeted by vaccination (those aged over one year and born since 1980), for whom vaccination status was known (n = 429), 304 (70.8%) cases occurred in individuals who were unvaccinated or incompletely vaccinated. At the national level, the number of reported cases appears to have peaked in March, but remains high. The increase is caused by transmission occurring through imported cases and locally acquired infections.
Germany has reported 207 confirmed and probable measles cases in 2025 and as of 8 July 2025, an increase of 19 cases since 13 June 2025.
Lithuania has reported six cases in 2025 as of 8 July 2025, an increase of one case since 12 June 2025.
The Netherlands has reported 475 cases of measles as of 2 July 2025, an increase of 38 cases since the end of May 2025. The reports mainly consist of individual cases and several small clusters with transmission occurring within families and at day-care centres. There is no indication of a national outbreak. In 2025, 51 cases were reported to have contracted measles abroad, with most of these infections occurring in Morocco (35). Other cases had travel histories to Greece, Romania, Viet Nam, Türkiye, Belgium, Uganda, Iran and Bosnia and Herzegovina. On 12 June 2025, RIVM reported a death from measles of an adult with a severe immune disorder.
Poland has reported 59 measles cases in 2025 and as of 30 June, an increase of eight cases since 31 May 2025.
Romania has reported 7 836 measles cases and eight deaths in 2025 and as of 30 June, an increase of 420 cases since May 2025. No new deaths have been reported in this reporting period. A decreasing trend is observed in 2025, with fewer cases reported per month compared to the same period in 2024.
Spain has reported 309 cases as of 29 June 2025 (303 cases reported as of 8 June 2025), 94 of which were imported and 87 related to imported cases.
Sweden has reported seven measles cases in 2025 and as of 8 July 2025, an increase of one since 14 May 2025.
Epidemiological summary for select countries outside of the EU/EEA with relevant epidemic intelligence updates:
Based on the WHO Provisional Monthly Measles data, as of 2 July 2025, the non-EU/EEA countries reporting most measles cases in the WHO EURO region in 2025 are Georgia (464), Kyrgyzstan (7 399), Tajikistan (1 676) and Ukraine (914).
In addition, in 2025, as of 9 July 2025, measles cases had been reported from Bosnia and Herzegovina (8), Montenegro (12), the Republic of Moldova (119), Serbia (187), and Switzerland (37).
England reported 529 laboratory confirmed cases from January to 3 July 2025, an increase of 209 cases since the last report on 10 April 2025. The majority of cases involve children under 10 years of age (68%).
Scotland reported 23 laboratory confirmed measles cases between January and March 2025. Of these, four cases had been imported and were related to travel outside of the United Kingdom.
Northern Ireland has reported 27 confirmed measles cases in 2025, as of 30 June, representing an increase of 24 cases since 30 April 2025.
According to the report published by Africa CDC on 28 June 2025, a total of 96 018 measles cases, 8 002 of which were confirmed, and 618 deaths were reported in the 18 countries: Cameroon, Chad, DRC, Ethiopia, Guinea, Kenya, Malawi, Mali, Mauritania, Morocco (40 000 cases and 79 deaths), Nigeria, Rwanda, Senegal, Somalia, South Africa, Sudan and Zambia.
According to the WHO Provisional Monthly Measles data, 37 992 cases of measles have been reported in 2025 and as of 2 July 2025 in the WHO Regional Office for the Eastern Mediterranean (WHO EMRO) countries: Afghanistan (7 037), Pakistan (12 390), Somalia (466) and Yemen (14 748).
According to the WHO Pan American Health Organization (WHO PAHO) report published on 20 June 2025, 7 150 confirmed cases were reported by nine countries, the majority of which were reported by Canada (3 391), Mexico (2 434), and the United States (US).
As of 1 July 2025, the US reported 1 267 confirmed measles cases in 2025, including three deaths in 38 jurisdictions. 92% of the cases were unvaccinated or had an unknown vaccination status.
On 24 June 2025, Bolivia declared a National Health Emergency due to the increase in measles cases in the country. From April 21 to June 24, 60 positive cases had already been reported in the country.
According to the WHO Provisional Monthly Measles data, in WHO South-East Asia (WHO SEARO) countries 13 201 cases have been reported in 2025, and as of 2 July 2025, mainly from India (10 543) and Indonesia (1 841).
According to a WHO Western Pacific Region (WHO WPRO) report for January to May 2025, there were 3 864 confirmed measles reported in the region in 13 countries. Most of the cases were reported in China (1 184) and Cambodia (1 097), followed by Mongolia (377), the Philippines (232) and Viet Nam (144).
For more information on the provisional number of cases outside the EU/EEA region, please visit the WHO website.
The numbers provided to WHO for EU/EEA countries are from TESSy data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.
ECDC assessment
Since March 2025, an overall decrease in reported cases has been observed. A further decline in case numbers is expected over the summer months, in line with the known seasonality of measles.
However, continued vigilance is essential due to suboptimal vaccination coverage for measles-containing vaccines (MCV) in several EU/EEA countries, the likelihood of importation from areas with ongoing transmission, and increased travel and population movement during the holiday period.
Although most recent cases were acquired through local or community transmission, travel-related cases continue to be reported.
Actions
ECDC is monitoring the measles situation through its epidemic intelligence activities. Data collected via epidemic intelligence supplement the monthly outputs that present measles surveillance data from EpiPulse Cases, which are routinely submitted by 30 EU/EEA countries.
ECDC urges EU/EEA public health authorities to focus on the following areas:
- Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time, as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
- Strive towards high-quality surveillance and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
- Increase the clinical awareness of health professionals, including reminding them of the importance of checking individuals' vaccination status ahead of travel.
- Healthcare professionals should be fully vaccinated.
- Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of suboptimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
- Address barriers and engage with under-served populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies in order to reduce inequalities in vaccine uptake.
- In light of the upcoming summer holiday season, travellers should check their vaccination status and consult their general practitioner to ensure they are up to date with recommended immunisations prior to departure.
ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response', published in February 2024 and the conclusions remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.